510(k) Report

510(k) · Cleared

Recalled · Class II · 2014

Advia Chemistry Hemoglobin A1C, Advia Chemistry A1C Calibrators

K081895510(k) TraditionalCleared Jan 8, 2009189-day reviewClass II21 CFR 864.7470Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Siemens Medical Solutions Diagnostics · LCP Assay, Glycosylated Hemoglobin

Cleared on Jan 8, 2009 as substantially equivalent to K011434 (Tosoh Medics, Inc., 2001) and 1 other predicate after a 189-day review. Its family tree reaches back 2 generations to 1997. 1 later device descends from it. It has been recalled 2 times.

Decided
Jan 8, 2009
Review
189 days
Class
Class II
Product code
LCP
Recalls
2
Predicates
2

Its longest line of descent runs back 2 generations to K972265 (1997). 4 ancestors in all, the oldest K904768 (1990). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2004: 1 other ancestor1990: 1 other ancestor2011: 1 descendant clearedK972265 · A1C 2.2 Plus - Automated Glycohemoglobin Analyzer · Tosoh Medics, Inc. · 1997K011434 · G7 Automated HPLC Analyzer · Tosoh Medics, Inc. · 2001 · recalled1990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 1 other ancestor 1 generation forward: 1 descendant K011434 · G7 Automated HPLC Analyzer · Tosoh Medics, Inc. · 2001 · recalledK972265 · A1C 2.2 Plus - Automated Glycohemoglobin Analyzer · Tosoh Medics, Inc. · 19970
  1. Root · 2 generations backK972265 A1C 2.2 Plus - Automated Glycohemoglobin AnalyzerTosoh Medics, Inc. · 1997
  2. 1 generation backK011434 G7 Automated HPLC AnalyzerTosoh Medics, Inc. · 2001 · Recalled
  3. This deviceK081895 Advia Chemistry Hemoglobin A1C, Advia Chemistry A1C CalibratorsSiemens Medical Solutions Diagnostics · 2009
  4. Descendant · cites it directly · 0 of its ownK110934 Advia Chemistry Hemoglobin A1C_3 (A1C_3) Automated Pretreatment AssaySiemens Healthcare Diagnostics · 2011 · Recalled

Most influential descendants

Showing 1 of 1 · See all
  • K110934Advia Chemistry Hemoglobin A1C_3 (A1C_3) Automated Pretreatment AssaySiemens Healthcare Diagnostics · 2011 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K972265A1C 2.2 Plus - Automated Glycohemoglobin AnalyzerTosoh Medics, Inc.1997—
−1K011434G7 Automated HPLC AnalyzerTosoh Medics, Inc.20012
0 (this device)K081895Advia Chemistry Hemoglobin A1C, Advia Chemistry A1C CalibratorsSiemens Medical Solutions Diagnostics2009—
+1K110934Advia Chemistry Hemoglobin A1C_3 (A1C_3) Automated Pretreatment AssaySiemens Healthcare Diagnostics20112

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201110
FIG. 1 — Lineage of K081895, 1997–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LCP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LCP device

  1. #1 K221326 Nova Allegro HbA1c Assay, Nova Allegro Analyzerscore 9.6 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K011434G7 Automated HPLC Analyzer
Summary page 1
…Device Device Name G7 Automated HPLC Analyzer - HbAl c Variant Analysis Mode Common name Glycosylated Hemoglobin Test 510(k) Number k011434 Manufacturer Tosoh Medics, Inc. Calibrator Predicate Device:…
Tosoh Medics, Inc.20012
*K041764The Vitros 5,1 FS Chemistry System
Summary page 1
…Predicate Device Device Name VITROS Chemistry Products Calibrator Kit 18 Common name Calibrator 510(k) Number k041764 Manufacturer Ortho-Clinical Diagnostics Siemens Healthcare Diagnostics (formerly Siemens Medical Solutions Diagnostic…
Ortho-Clinical Diagnostics2004—

Also cleared against K011434: 4 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K110934Advia Chemistry Hemoglobin A1C_3 (A1C_3) Automated Pretreatment AssaySiemens Healthcare Diagnostics20110

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 6, 2014Class IIZ-2643-2014Software designThe ADVIA Chemistry Systems A1c_3 method may exhibit a percent bias of -9% to +11% for hemoglobin (Hb)A1c samples when using A1c_3 Calibrator lots 3HD044 and 3LD068. Depending on quality control limits, this issue may not have been…
Jul 30, 2013Class IIZ-2135-2013Software designSiemens confirmed that the ADVIA¿ Chemistry Systems HbA1c method exhibits a positive bias of up to 12% for patient and CAP survey samples due to over-recovery when using A1c_3 Calibrator lots 1MD014, 1BD063, and 2GD014. The established…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 2 companies; a new generation was cleared every 7.3 years on median.
  • 2 of the 4 ancestors have a recall of any class.
  • Of its descendants, K110934 (Siemens Healthcare Diagnostics, 2011) has gone furthest, with 0 descendants of its own.
  • 4 other devices also cite its predicate K011434.

How does its category compare?

All LCP devices

LCP Assay, Glycosylated Hemoglobin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · LCP

1in 2024

2007: 72008: 52009: 62010: 22011: 102012: 92013: 22014: 82015: 32016: 22017: 52018: 22019: 42020: 12023: 22024: 1
2007high 10 (2011) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LCP

269in 2019

2007: 133 days median2008: 206 days median2009: 158 days median2011: 176 days median2012: 143 days median2014: 127 days median2015: 239 days median2017: 218 days median2019: 269 days median
2007high 269 (2019) · low 127 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LCP

1in 2025

2007: 12008: 32009: 62010: 52011: 512013: 42014: 22015: 22016: 62017: 12018: 12022: 12024: 12025: 1
2007high 51 (2011) · low 0 (2012)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LCP

22in 2025

2007: 52008: 112009: 152010: 42011: 272012: 512013: 1932014: 1822015: 642016: 292017: 1492018: 1,9112019: 1142020: 132021: 72022: 82023: 272024: 392025: 22
2007high 1,911 (2018) · low 4 (2010)2025

MAUDE reports naming product code LCP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007713315
20085206311
20096158615
20102—54
2011101765127
20129143051
20132—4193
201481272182
20153239264
20162—629
201752181149
20182—11,911
201942690114
20201—013
20210—07
20220—18
20232—027
20241—139
20250—122
20260—0—

What is it indicated for?

The ADVIA® Chemistry Hemoglobin A1c method is for in vitro diagnostic use in the quantitative determination of Hemoglobin A1c, a diabetes marker, in whole blood on the ADVIA Chemistry systems. Such measurements are used for monitoring the long-term glycemic control of persons with diabetes. The A1c and total hemoglobin (tHb) values generated as part of the HbA1cN and HbA1cI results are intended for use in the calculation of the A1c / total hemoglobin…

Read the full statement (125 words)

The ADVIA® Chemistry Hemoglobin A1c method is for in vitro diagnostic use in the quantitative determination of Hemoglobin A1c, a diabetes marker, in whole blood on the ADVIA Chemistry systems. Such measurements are used for monitoring the long-term glycemic control of persons with diabetes. The A1c and total hemoglobin (tHb) values generated as part of the HbA1cN and HbA1cI results are intended for use in the calculation of the A1c / total hemoglobin ratio, and must not be used individually for diagnostic purposes.

*Note: HbA1cN reports HbA1c in % and HbA1cI reports HbA1c in mmol/mol

The ADVIA® Chemistry A1c Calibrators are for in vitro diagnostic use in the calibration of the A1c and total hemoglobin methods (Automated and Manual Pretreatment) on the ADVIA Chemistry Systems.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K081895: Advia Chemistry Hemoglobin A1C, Advia Chemistry A1C Calibrators.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K081895

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026